燃石醫學 BNR 深 滬
已收盤 04-02 16:00:00 美东时间
16.20
-0.100
-0.61%
華盛通- 最 高17.05
- 今 開16.79
- 成交量 5.59万股
- 最 低 16.20
- 昨 收 16.30
- 總市值 1.74亿
- 52周最高 41.72
- 市盈率 靜 --
- 換手率 0.52%
- 52周最低 2.18
- 委 比 33.33%
- 總股本 1076.66万
- 歷史最高 397.50
- 量 比 1.04
- 振 幅 5.21%
- 歷史最低 2.18
- 每 手 1
- 風險率 9.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多燃石医学2025年第四季度经调整后EBITDA首次转正，单季度盈利37万元
经济观察网 燃石医学2025年第四季度经调整后EBITDA首次转正（单季度盈利37万元人民币），且经营现金流连续两个季度转正，这被视为扭亏前的重要里程碑。投资者...
今天 00:08
Burning Rock Announces Founder’s Purchase of Its ADSs
Burning Rock Biotech's founder and CEO, Mr. Yusheng Han, has purchased 72,733 ADSs totaling $1.36 million over two consecutive post-earnings trading windows, reflecting his confidence in the company's future.
04-02 10:25
Burning Rock Biotech Q4 EPS $(0.20) Up From $(1.10) YoY, Sales $18.063M Up From $17.265M YoY
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 81.82 percent increase over losses of $(1.10) per share from the same period last year. The company reported $18.063 million in
03-12 19:27
“聚能创新 共话湾区”2026生物医药上市公司春季路演 解码创新药投资新逻辑
2026年1月22日-23日，由乐赢投资、国投证券国际、投研会联合主办，智信财经、东莞市私募基金业协会、建国路128号联袂承办，以“聚能创新 共话湾区”为主题举...
01-26 16:22
Burning Rock Biotech Breast Cancer NGS CDx Kit Enters CMDE Priority Review Channel
Burning Rock Biotech Breast Cancer NGS CDx Kit Enters CMDE Priority Review Channel Burning Rock Biotech Ltd. announced that its self-developed "OncoScreen® BCMatch Tissue Kit," a breast cancer NGS companion diagnostic (CDx) kit, has entered the Priority Review Channel of the Center for Medical Devic
01-26 15:13
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers IO Biotech (NASDAQ:IOBT) stock increased by 76.7% to $0.37 during Thur...
01-23 01:05
